Day: March 17, 2022

Bombardier Completes Partial Redemption of $200,000,000 of its 7.500% Senior Notes due 2024 and $200,000,000 of its 7.500% Senior Notes due 2025

Written by Customer Service on March 17, 2022. Posted in Public Companies.

MONTRÉAL, March 17, 2022 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has redeemed $200 million principal amount of its outstanding 7.500% Senior Notes due 2024 (the “2024 Notes”) and $200 million principal amount of its outstanding 7.500% Senior Notes due 2025 (the “2025 Notes” and, together with the 2024 Notes, the “Redemption Notes”), in each case as set forth in the respective notices of partial redemption issued February 15, 2022. Payment of the redemption price and surrender of the respective Redemption Notes for redemption are being made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. “Debt reimbursement is one of the key strategic priorities for our company and the completion of today’s paydown using cash from...

Targa Resources Corp. Executes Agreements to Acquire Bolt-On Assets for $200 Million

Written by Customer Service on March 17, 2022. Posted in Mergers And Acquisitions.

HOUSTON, March 17, 2022 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that it has executed agreements to acquire Southcross Energy Operating LLC and its subsidiaries in South Texas for $200 million. Transaction HighlightsAttractive acquisition price represents approximately 4 times adjusted EBITDA multiple Further synergy potential to reduce acquisition multiple over time Potential to move a currently idle 200 million cubic feet per day plant Fee-based contracts, with the vast majority of volumes being low pressure wellhead gathering Continued simplification through acquisition of remaining T2 joint venture interestsWells Fargo Securities, LLC is serving as Targa’s financial advisor and Winston & Strawn LLP is acting as Targa’s legal counsel on the transaction. The acquisition...

Partners Value Split Corp. Announces Exercise of Underwriters’ Option

Written by Customer Service on March 17, 2022. Posted in Public Companies.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO, March 17, 2022 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today that as a result of strong investor demand for its previously announced offering, the underwriters have exercised their option to increase the size of the offering to 6,000,000 Class AA Preferred Shares, Series 13 (the “Series 13 Preferred Shares”). The Series 13 Preferred Shares will be issued at a price of $25.00 per share, for gross proceeds of $150,000,000. The Series 13 Preferred Shares are being issued on a bought deal basis to a syndicate of underwriters led by Scotiabank, BMO Capital Markets, CIBC Capital Markets, RBC Capital Markets and TD Securities Inc. The Series 13 Preferred Shares will carry a fixed coupon of 4.45% and...

Vasta Platform Limited to Report Fourth Quarter 2021 Financial Results on March 24, 2022

Written by Customer Service on March 17, 2022. Posted in Public Companies.

SÃO PAULO, Brazil, March 17, 2022 (GLOBE NEWSWIRE) — Vasta Platform Limited (NASDAQ: VSTA) today announces that it will report fourth quarter 2021 financial results for the period ended December 30, 2021, after the market closes on Thursday, March 24, 2022. The Company will host a corresponding conference call and webcast on the same day, March 24, at 5:00 p.m. Eastern time. Investors may listen to the conference call (ID: 6749694) by dialing +1 (833) 519-1336 or +1 (914) 800-3898. A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.vastaplatform.com. About Vasta Vasta is a leading, high-growth education company in Brazil powered by technology, providing end-to-end educational and digital solutions that cater to all needs of private schools operating...

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

IND allowed by U.S. FDA and Phase 1 study of BDTX-1535 initiated for the treatment of GBM and NSCLC including those with CNS metastases Preclinical data demonstrating the potential of MasterKey programs BDTX-1535, CNS-BRAF (BDTX-4933), and FGFR presented at AACR-NCI-EORTC (ANE) International Conference Appointed Elizabeth Montgomery as Chief People Officer, who brings nearly two decades of global human resources leadership experience in life sciences Cash, cash equivalents, and investments of $209.8 million as of December 31, 2021, expected to be sufficient to fund operations into 2024CAMBRIDGE, Mass. and NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today reported financial results...

Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

NEWARK, N.J., March 17, 2022 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL), an early-stage novel cancer and immune metabolism therapeutics company, today reported its financial results for the three and six months ended January 31, 2022. The end of our second fiscal quarter marks a beginning for the reorganized and focused Rafael Holdings with Bill Conkling assuming the responsibilities of Chief Executive Officer from Ameet Mallik as of February 1, 2022. The Company is focused on accelerating the development of our novel cancer and immune metabolism pipeline and exploring external opportunities to enhance the value of our company. “We are fortunate to have a core team of high caliber experienced senior pharmaceutical executives to lead R&D and the critical operational functions of the Company. We are enthusiastic about...

Usio Announces Record Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Full Year Revenues up 92% as Fourth Quarter Revenues Rise 86% Fifth Consecutive Year of Record Revenue Strong Momentum Expected to Drive Continued Growth with 18-20% Increase in Revenue and Continued Positive Adjusted EBITDA Anticipated in Fiscal 2022 SAN ANTONIO, March 17, 2022 (GLOBE NEWSWIRE) — Usio, Inc: (Nasdaq:USIO), a leading, cloud-based, integrated FinTech electronic payment solutions provider, today announced financial results for the fourth quarter and year 2021, which ended December 31, 2021. Louis Hoch, President and Chief Executive Officer of Usio, said, “The fourth quarter was a strong finish to a year of record financial performance, with revenue for the year of $61.9 million, up 92% and positive adjusted EBITDA increasing by nearly $5 million compared to 2020. For the quarter, revenues were a record $17.4 million,...

Root, Inc. to Participate in the Jefferies Insurtech Conference

Written by Customer Service on March 17, 2022. Posted in Public Companies.

COLUMBUS, Ohio, March 17, 2022 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced that Alex Timm, Co-Founder and CEO, will participate in a fireside chat at the Jefferies Insurtech Conference on Monday, March 21, 2022 at 4:20 p.m. ET. The fireside chat will be available live on the Jefferies website, and a replay of the webcast will be available for a limited time after the presentation concludes. About Root, Inc.  Root, Inc. is the parent company of Root Insurance Company. Root is revolutionizing insurance through data science and technology to provide consumers a personalized, easy, and fair experience. Media: press@joinroot.com Investor Relations: Christine Patrick VP, Investor Relations and Treasurer ir@joinroot.c...

CymaBay Announces Appointment of Éric Lefebvre, M.D. to Board of Directors

Written by Customer Service on March 17, 2022. Posted in Public Companies.

NEWARK, Calif., March 17, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced the appointment of Dr. Éric Lefebvre to its Board of Directors. “We are excited to be welcoming Éric to the Board. Éric’s extensive experience in the pharmaceutical industry as an executive focused on clinical development, medical affairs, business development and life-cycle strategy and more than 10 years of experience developing drugs in liver disease indications make him a perfect addition to our Board. We look forward to Éric helping guide us through our next phase of development and commercialization,” said Dr. Robert Wills, CymaBay’s Chairman of the Board. “We are incredibly fortunate...

SightGlass Vision Joint Venture Begins Operation

Written by Customer Service on March 17, 2022. Posted in Public Companies.

EssilorLuxottica and CooperCompanies initiative accelerates commercialization of innovative myopia management technologies CHARENTON-LE-PONT, France and SAN RAMON, Calif., March 17, 2022 (GLOBE NEWSWIRE) — EssilorLuxottica and CooperCompanies are pleased to announce the finalization of their joint venture agreement for SightGlass Vision. This collaboration of two global vision care leaders accelerates the commercialization of novel spectacle lens technologies to expand the myopia management category. SightGlass Vision’s Diffusion Optics Technology™ incorporates thousands of micro-dots into the lens that softly scatter light to reduce contrast on the retina, which is intended to reduce myopia progression in children.1 “As a global leader with a 30-year track record in myopia research, we have been developing the myopia management...

Day: March 17, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals